Neumora Therapeutics operates as a clinical-stage biotechnology company pioneering precision medicines for brain diseases through the integration of data science and neuroscience.
Syllable Life Sciences employs advanced machine learning and computer vision technologies to automatically interpret human and laboratory animal body language. The company develops data models and tools to analyze behavioral data, with a focus on treating neurological conditions such as Parkinson's, Alzheimer's, and Lou Gehrig's disease. They collaborate with major pharmaceutical companies to enhance drug development and have successfully applied their system for drug classification. Syllable Life Sciences seeks professionals with expertise in computer vision and time-series modeling to further strengthen their behavioral analysis capabilities.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.